BNP Paribas Aktienanleihe RNL 26..../ DE000PC7FNV1 /
21/06/2024 21:40:18 | Var.-0.400 | Denaro21:59:59 | Lettera21:59:59 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
100.820EUR | -0.40% | 100.820 Quantità in denaro: 20,000 |
100.920 Quantità in lettera: 20,000 |
RENAULT INH. EO... | 42.00 EUR | 26/09/2024 | Call |
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Dir...
GlobeNewswire
02:45
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
GlobeNewswire
01:44
ROSEN, LEADING INVESTOR COUNSEL, Encourages UiPath, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
01:35
ROSEN, LEADING INVESTOR COUNSEL, Encourages NIKE, Inc. Investors to Secure Counsel Before Important ...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, In...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporati...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FutureFuel Corp....
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeu...
GlobeNewswire
22/06
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...